|
1
|
Scaffidi P, Misteli T and Bianchi ME:
Release of chromatin protein HMGB1 by necrotic cells triggers
inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bell CW, Jiang W, Reich CF III and
Pisetsky DS: The extracellular release of HMGB1 during apoptotic
cell death. Am J Physiol Cell Physiol. 291:C1318–C1325. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andrassy M, Volz HC, Igwe JC, et al:
High-mobility group box-1 in ischemia-reperfusion injury of the
heart. Circulation. 117:3216–3226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu X, Jiang H, Bai Q, et al: Increased
serum HMGB1 is related to the severity of coronary artery stenosis.
Clin Chim Acta. 406:139–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andrassy M, Volz HC, Riedle N, et al:
HMGB1 as a predictor of infarct transmurality and functional
recovery in patients with myocardial infarction. J Intern Med.
270:245–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu X, Zhou W, Bai Q, et al: Increased
serum high mobility group box 1 protein in patients with atrial
fibrillation. Biomed Aging Pathol. 1:52–55. 2011. View Article : Google Scholar
|
|
7
|
Frangoginis NG, Smith CW and Entman ML:
The inflammatory response in myocardial infarction. Cardiovasc Res.
53:31–47. 2002. View Article : Google Scholar
|
|
8
|
Hu X, Fu W and Jiang H: HMGB1: a potential
therapeutic target for myocardial ischemia and reperfusion injury.
Int J Cardiol. 155:4892012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones SP, Gibson MF, Rimmer DM III, et al:
Direct vascular and cardioprotective effects of rosuvastatin, a new
HMG-CoA reductase inhibitor. J Am Coll Cardiol. 40:1172–1178. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nangle MR, Cotter MA and Cameron NE:
Effects of rosuvastatin on nitric oxide-dependent function in aorta
and corpus cavernosum of diabetic mice: relationship to cholesterol
biosynthesis pathway inhibition and lipid lowering. Diabetes.
52:2396–2402. 2003. View Article : Google Scholar
|
|
11
|
Susic D, Varagic J, Ahn J, et al:
Beneficial pleiotropic vascular effects of rosuvastatin in two
hypertensive models. J Am Coll Cardiol. 42:1091–1097. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weinberg EO, Scherrer-Crosbie M, Picard
MH, et al: Rosuvastatin reduces experimental left ventricular
infarct size after ischemia-reperfusion injury but not total
coronary occlusion. Am J Physiol Heart Circ Physiol.
288:H1802–H1809. 2005. View Article : Google Scholar
|
|
13
|
Ke D, Fang J, Fan L, et al: Regulatory T
cells contribute to rosuvastatin-induced cardioprotection against
ischemia-reperfusion injury. Coron Artery Dis. 24:334–341. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Zhang X, Liu L, et al:
Atorvastatin protects rat brains against permanent focal ischemia
and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB
expression. Neurosci Lett. 471:152–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin D, Wu Y, Zhao L, et al: Atorvastatin
inhibits serum HMGB1 level in patients with hyperlipidemia. Exp
Ther Med. 4:1124–1126. 2012.PubMed/NCBI
|
|
16
|
Hu X, Zhou X, He B, et al: Minocycline
protects against myocardial ischemia and reperfusion injury by
inhibiting high mobility group box 1 protein in rats. Eur J
Pharmacol. 638:84–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McTaggart F, Buckett L, Davidson R, et al:
Preclinical and clinical pharmacology of Rosuvastatin, a new
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J
Cardiol. 87:28B–32B. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bell RM and Yellon DM: Atorvastatin,
administered at the onset of reperfusion, and independent of lipid
lowering, protects the myocardium by up-regulating a pro-survival
pathway. J Am Coll Cardiol. 41:508–515. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang D, Shi Y, Kang R, et al: Hydrogen
peroxide stimulates macrophages and monocytes to actively release
HMGB1. J Leukoc Biol. 81:741–747. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsung A, Klune JR, Zhang X, et al: HMGB1
release induced by liver ischemia involves Toll-like receptor 4
depedent reactive oxygen species production and calcium-mediated
signaling. J Exp Med. 204:2913–2923. 2007. View Article : Google Scholar
|
